转移瘤的免疫治疗可行吗？ - Suppr | 超能文献

Is the immunotherapy of metastasis feasible?

作者信息

Frost P, Kerbel R S

出版信息

Symp Fundam Cancer Res. 1986;38:149-57.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Is the immunotherapy of metastasis feasible?转移瘤的免疫治疗可行吗？

Symp Fundam Cancer Res. 1986;38:149-57.

2

Mutagen-induced antigenic variants of tumor cells.诱变剂诱导的肿瘤细胞抗原变体

Symp Fundam Cancer Res. 1986;38:139-48.

3

Cancer vaccines: pessimism in check.癌症疫苗：谨慎看待悲观情绪。

Nat Med. 2004 Dec;10(12):1278-9; author reply 1279-80. doi: 10.1038/nm1204-1278.

4

Regulatory T cells, tumour immunity and immunotherapy.调节性T细胞、肿瘤免疫与免疫疗法。

Nat Rev Immunol. 2006 Apr;6(4):295-307. doi: 10.1038/nri1806.

5

Analyses and perspectives in cancer immunotherapy.癌症免疫疗法的分析与展望

Biomed Pharmacother. 2006 Nov;60(9):621-8. doi: 10.1016/j.biopha.2006.07.092. Epub 2006 Aug 28.

6

Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.增强的TNP反应性辅助性T细胞活性及其在诱导导致肿瘤消退的增强肿瘤免疫中的应用。

J Immunol. 1984 Mar;132(3):1571-7.

7

Antigenic tumor cell variants obtained with mutagens.通过诱变剂获得的抗原性肿瘤细胞变体。

Adv Cancer Res. 1983;39:121-51. doi: 10.1016/s0065-230x(08)61034-9.

8

Comparative study on Lewis lung tumor lines with 'low' and 'high' metastatic capacity. I. Growth rate, morphology and resistance to host defence.

Invasion Metastasis. 1985;5(3):159-69.

9

Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).肿瘤特异性独特型疫苗。II. 肿瘤及内影像抗原（Ab2β）诱导的肿瘤相关网络反应分析。

J Immunol. 1987 Jul 1;139(1):271-8.

10

Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.转移性肿瘤变体对肿瘤特异性细胞毒性T淋巴细胞的抗性并非由于小鼠细胞中限制性主要组织相容性复合体分子表达缺陷所致。

Cancer Res. 1984 Nov;44(11):5305-13.

引用本文的文献

1

Mutagen-induced Imm+ variants: the need for viable and cloned Imm+ variants for effective protection against a primary murine tumor and its metastases.诱变剂诱导的免疫阳性变体：需要有活力且经过克隆的免疫阳性变体来有效抵御原发性小鼠肿瘤及其转移灶。

Clin Exp Metastasis. 1989 Jan-Feb;7(1):97-105. doi: 10.1007/BF02057184.